FDA issued a Warning Letter to Acorda Therapeutics Inc. on 5/10/2012 for a previous inspection.
483 Acorda Therapeutics Jan 2013

483 Acorda Therapeutics Jan 2013

$119 - Not in Stock

FDA investigators audited the Acorda Therapeutics - Ardsley, NY, United States facility and issued inspectional observations (via FDA 483) on 16 Jan 2013.

Product details

  • Category: Human Drugs
  • Inspection end: 16 Jan 2013
  • Location: Ardsley, United States
  • FEI: 3002457563
Order